1
EXHIBIT 10.11
SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT
This Series B Convertible Preferred Stock Purchase Agreement (the
"AGREEMENT") dated as of July 28, 1998 is entered into by and among Sequoia
Software Corporation, a Maryland corporation (the "COMPANY"), the investors
listed on Schedule I hereto (the "NEW INVESTORS"), Anthem Capital, L.P., a
Delaware limited partnership ("ANTHEM"), NEPA Venture Fund II, L.P., a
Pennsylvania Limited Partnership ("NEPA"), such other purchasers as may from
time to time purchase the Series B Preferred Stock (as defined below) directly
from the Company (the "FUTURE INVESTORS") (each of the foregoing parties other
than the Company being referred to individually as a "PURCHASER" and
collectively as the "PURCHASERS"), Xxxx Wesker ("WESKER") and Xxxx Xxxxx
("SETHI") (individually Wesker and Sethi being referred to as a "FOUNDER" and
collectively, the "FOUNDERS"), and with respect to Sections, 7.8, 7.14 and 7.15
hereof of only, Xxxxxxx X. Faint, Jr. ("FAINT"), Xxxxxxx X. Xxxx ("HOMA") and
Xxxxx X. Xxxxxxxxxx ("XXXXXXXXXX").
In consideration of the premises, mutual promises and covenants
contained in this Agreement, and for other good and valuable consideration, the
receipt and sufficiency of which are here acknowledged, the parties hereto agree
as follows:
1. Authorization and Sale of Series B Preferred.
1.1 Authorization. The Company has, or before the Initial Closing and
each Subsequent Closing (as defined in Section 2) will have, duly authorized the
sale and issuance of 9,647,920 shares of its Series B Convertible Preferred
Stock, $0.001 par value per share (the "SERIES B PREFERRED"), having the rights,
restrictions, privileges and preferences set forth in the Amended and Restated
Articles of Incorporation attached hereto as Exhibit A (the "ARTICLES OF
INCORPORATION"). The Company has adopted and filed the Articles of Incorporation
with the Maryland State Department of Assessments and Taxation.
1.2 Sale of Shares. Subject to the terms and conditions of this
Agreement, at the Initial Closing, the Company will sell and issue to each of
the Purchasers, and each of the Purchasers will purchase, the number of shares
of Series B Preferred set forth opposite such Purchaser's name on Exhibit B for
the purchase price of $0.6763 per share. The Company's agreement with each
Purchaser is a separate agreement, and the sale of Series B Preferred to each
Purchaser is a separate sale.
1.3 Use of Proceeds. The Company will use the proceeds from the sale of
the Series B Preferred for working capital and product development.
2. Initial Closing and Subsequent Closings
2.1 The Initial Closing. The closing of the sale and purchase of
5,212,019 shares of the Series B Preferred under this Agreement (the "INITIAL
CLOSING") shall take place at
2
the offices of Anthem Capital, L.P., Suite 800, 00 Xxxxx Xxxxxxx Xxxxxx,
Xxxxxxxxx, XX 00000-0000 at 10:00 a.m. on July 27, 1998, or at such other time,
date and place as are mutually agreeable to the Company and special counsel to
the Purchasers, but in no event later than July 31, 1998. At the Initial
Closing, the Company will deliver to each Purchaser a certificate for the number
of Series B Preferred being purchased by such Purchaser, registered in the name
of such Purchaser, against payment to the Company of the purchase price
therefor, by wire transfer, check, or other method acceptable to the Company.
The date of the Initial Closing is hereinafter referred to as the "INITIAL
CLOSING DATE." If at the Initial Closing any of the conditions specified in
Section 6 shall not have been fulfilled, each Purchaser shall, at his or its
election, be relieved of all of his or its obligations under this Agreement
without thereby waiving any other rights he or it may have by reason of such
failure or such non-fulfillment.
2.2 Subsequent Closings.
(a) The second closing (the "SECOND CLOSING") of the sale and
purchase of the Shares under this Agreement shall take place on or prior to
September 30, 1998, at a time and place as are mutually agreeable to the
Company, the Future Investors and special counsel to Anthem. At the Second
Closing, the Company will deliver to Anthem a notice of the number of Shares
being purchased by the Future Investors and the total purchase price thereof. In
no event shall the purchase price of Shares purchased at the Second Closing be
less than $500,000. The date of the Second Closing is hereinafter referred to as
the "SECOND CLOSING DATE". The Second Closing and any subsequent closings may
each be referred to as a "SUBSEQUENT CLOSING" and the Second Closing Date and
subsequent closing dates may each be referred to as a "SUBSEQUENT CLOSING DATE".
3. Representations of the Company. The Company hereby represents and
warrants to each Purchaser as follows:
3.1 Organization and Standing. The Company is a corporation duly
organized, validly existing and in good standing under the laws of the State of
Maryland and has full corporate power and authority to conduct its business as
presently conducted and as proposed to be conducted by it and to enter into and
perform this Agreement and to carry out the transactions contemplated by this
Agreement. The Company is duly qualified to do business as a foreign corporation
and is in good standing in every jurisdiction in which the failure to so qualify
would have a material adverse effect on the operations or financial condition of
the Company. The Company has furnished to special counsel to Anthem true and
complete copies of its Articles of Incorporation and By-laws, each as amended to
date and presently in effect.
3.2 Capitalization. The authorized capital stock of the Company
(immediately prior to the Initial Closing) will consist of 33,000,000 shares of
common stock, $0.001 par value per share (the "COMMON STOCK"), of which (i)
10,149,614 shares are issued and outstanding, and (ii) 17,712,920 shares of
Preferred Stock, $0.001 par value per share, 8,065,000 of which are designated
Series A Convertible Preferred Stock (the "SERIES A PREFERRED"), 8,064,877 of
which shares of Series A Preferred are issued and outstanding and 9,647,920 of
- 2 -
3
which are designated as Series B Preferred none of which are issued and
outstanding. All of the issued and outstanding shares of Common Stock have been
duly authorized and validly issued and are fully paid and nonassessable. Except
as set forth in Schedule 3.2 hereto or provided in this Agreement or the
Registration Rights Agreement (as defined in Section 5.4 below), (i) no
subscription, warrant, option, convertible security or other right (contingent
or otherwise) to purchase or acquire any shares of capital stock of the Company
is authorized or outstanding, (ii) there is not any commitment of the Company to
issue any subscription, warrant, option, convertible security or other such
right or to issue or distribute to holders of any shares of its capital stock
any evidences of indebtedness or assets of the Company, and (iii) the Company
has no obligation (contingent or otherwise) to purchase, redeem or otherwise
acquire any shares of its capital stock or any interest therein or to pay any
dividend or make any other distribution in respect thereof. Except as set forth
on Schedule 3.2 hereto or provided in this Agreement, no person or entity is
entitled to (i) any preemptive or similar right with respect to the issuance of
any capital stock of the Company, or (ii) any rights with respect to the
registration of any capital stock of the Company under the Securities Act of
1933, as amended (the "SECURITIES ACT"). All of the issued and outstanding
shares of Common Stock have been offered, issued and sold by the Company in
compliance with applicable Federal and state securities laws. To the best of the
Company's knowledge, no stockholder of the Company has granted options or other
rights to purchase any shares of Common Stock from such stockholder.
3.3 Subsidiaries. The Company has no subsidiaries and does not own or
control, directly or indirectly, shares of capital stock of any other
corporation, or any interest in any partnership, joint venture or other
non-corporate business entity or enterprise.
3.4 Stockholder List and Agreements. Attached as Schedule 3.4 is a true
and complete list of the stockholders of the Company, showing the number of
shares of Common Stock, Series A Preferred, or other securities of the Company
held by each stockholder as of the date of this Agreement and the consideration
paid to the Company, if any, for such shares. Except with respect to the holders
of shares of Series A Preferred and as contemplated by this Agreement, there are
no agreements, written or oral, between the Company and any holder of its
capital stock, or, to the best knowledge of the Company, among any holders of
its capital stock, relating to the acquisition (including, without limitation,
rights of first refusal or preemptive rights), disposition or voting of the
capital stock of the Company.
3.5 Issuance of Shares. The issuance, sale and delivery of the Series B
Preferred in accordance with this Agreement, and the issuance and delivery of
the shares of Common Stock issuable upon conversion of the Series B Preferred
(the "SERIES B CONVERSION SHARES"), have been, or will be on or prior to the
Initial Closing and any Subsequent Closing, duly authorized and, as the case may
be, reserved for issuance, by all necessary corporate action on the part of the
Company, and the Series B Preferred when so issued, sold and delivered against
payment therefor in accordance with the provisions of this Agreement, and the
Series B Preferred Conversion Shares, when issued upon conversion of the Series
B Preferred, will be duly and validly issued, fully paid and non-assessable.
- 3 -
4
3.6 Authority for Agreement. The execution, delivery and performance by
the Company of this Agreement and all other agreements required to be executed
by the Company on or prior to Initial Closing and any Subsequent Closing
pursuant to Section 5.4 (the "ANCILLARY AGREEMENTS"), and the consummation by
the Company of the transactions contemplated hereby and thereby, have been duly
authorized by all necessary corporate action. This Agreement and the Ancillary
Agreements have been duly executed and delivered by the Company and constitute
valid and binding obligations of the Company enforceable in accordance with
their respective terms. The execution and performance of the transactions
contemplated by this Agreement and the Ancillary Agreements and compliance with
their provisions by the Company will not violate any provision of law and will
not conflict with or result in any breach of any of the terms, conditions or
provisions of, or constitute a default under, its Articles of Incorporation or
By-laws (each as amended to date and presently in effect), or any indenture,
lease, agreement or other instrument to which the Company is a party or by which
it or any of its properties is bound, or any decree, judgment, order, statute,
rule or regulation applicable to the Company.
3.7 Governmental Consents. No consent, approval, order or authorization
of, or registration, qualification, designation, declaration or filing with, any
governmental authority is required on the part of the Company in connection with
the execution and delivery of this Agreement, the offer, issue, sale and
delivery of the Series B Preferred, the issue and delivery of the Series B
Conversion Shares or the other transactions to be consummated at the Initial
Closing and any Subsequent Closing, as contemplated by this Agreement, except
such filings as shall have been made prior to and shall be effective on and as
of the Initial Closing or Subsequent Closing. Based on the representations made
by each of the Purchasers in Section 4 of this Agreement and the disclosures to
and covenants by the Purchasers in the Registration Rights Agreement described
in Section 5.4 below, the offer and sale of the Series B Preferred to each of
the Purchasers will be in compliance with applicable Federal and state
securities laws.
3.8 Litigation. There is no action, suit, proceeding or investigation
pending, or, to the best of the Company's knowledge, any basis therefor or
threat thereof, against the Company or any of the Founders that questions the
validity of this Agreement or the right of the Company or any of the Founders to
enter into it, or that might result, either individually or in the aggregate, in
any material adverse change in the assets, condition (financial or otherwise),
business or prospects of the Company, nor is there any litigation pending, or,
to the best of the Company's knowledge, any basis therefor or threat thereof,
against the Company or any of the Founders by reason of the past employment
relationships of any of the Founders or the Company's employees, the proposed
activities of the Company, or negotiations by the Company or any of the Founders
with possible investors in the Company.
3.9 Financial Statements. The Company has furnished to each Purchaser a
complete and correct copy of the unaudited balance sheet of the Company (the
"BALANCE SHEET") as of March 31, 1998 (the "BALANCE SHEET DATE") and the related
statements of operations and cash flows for the three months then ended,
compiled by the Company (collectively, the "FINANCIAL STATEMENTS"). The
Financial Statements are complete and correct, are in accordance
- 4 -
5
with the books and records of the Company and present fairly the financial
condition and results of operations of the Company, as at the dates and for the
periods indicated, and have been prepared in accordance with generally accepted
accounting principles consistently applied, except that the Financial Statements
have been prepared for the internal use of management and may not be in
accordance with generally accepted accounting principles because of the absence
of footnotes normally contained therein and are subject to normal year-end audit
adjustments which in the aggregate will not be material.
3.10 Absence of Liabilities. Except as disclosed in Schedule 3.10, the
Company did not have, at the Balance Sheet Date, any liabilities of any type
which in the aggregate exceeded $25,000, whether absolute or contingent, which
were not fully reflected on the Balance Sheet, and, since the Balance Sheet
Date, the Company has not incurred or otherwise become subject to any such
liabilities or obligations except in the ordinary course of business.
3.11 Taxes. The amount shown on the Balance Sheet as provision for
taxes is sufficient in all material respects for payment of all accrued and
unpaid Federal, state, county, local and foreign taxes for the period then ended
and all prior periods. The Company has filed or has obtained presently effective
extensions with respect to all Federal, state, county, local and foreign tax
returns which are required to be filed by it, such returns are true and correct
and all taxes shown thereon to be due have been timely paid, with any exceptions
permitted by any taxing authority not having a materially adverse effect on the
Company. Federal income tax returns of the Company have not been audited by the
Internal Revenue Service, and no controversy with respect to taxes of any type
is pending or, to the knowledge of the Company, threatened. Neither the Company
nor any of its stockholders has ever filed (a) an election pursuant to Section
1362 of the Internal Revenue of 1986, as amended (the "CODE"), that the Company
be taxed as an S Corporation or (b) consent pursuant to Section 341(f) of the
Code relating to collapsible corporations. The Company's net operating losses
for federal income tax purposes, as set forth in the Financial Statements, are
not subject to any limitations imposed by Section 382 of the Code, and
consummation of the transactions contemplated by this Agreement or by any other
agreement, understanding or commitment, contingent or otherwise, to which the
Company is a party or by which it is otherwise bound will not have the effect of
limiting the Company's ability to use such net operating losses in full to
offset such taxable income.
3.12 Property and Assets. The Company has good title to all of its
material properties and assets, including all properties and assets reflected in
the Balance Sheet, except those disposed of since the date thereof in the
ordinary course of business, and none of such properties or assets is subject to
any mortgage, pledge, lien, security interest, lease, charge or encumbrance
other than those the material terms of which are described in the Balance Sheet
or in Schedule 3.12.
3.13 Patents and Trademarks. Set forth on Schedule 3.13 is a true and
complete list of all patents, patent applications, trademarks, service marks,
trademark and service xxxx applications, trade names, copyrights and licenses
presently owned or held by the Company, any or all of the Founders or necessary
for the conduct of the Company's business as
- 5 -
6
conducted and as proposed to be conducted, as well as any agreement under which
the Company has access, to any confidential information used by the Company in
its business (the "INTELLECTUAL PROPERTY RIGHTS"). The Company owns, or has the
right to use under the agreements or upon the terms described in Schedule 3.13,
all of the Intellectual Property Rights. To the best of the Company's knowledge,
the business proposed by the Company will not cause the Company to infringe or
violate any of the patents, trademarks, service marks, trade names, copyrights,
licenses, trade secrets or other proprietary rights of any other person or
entity. The Company is not aware that any Founder or other employee is obligated
under any contract (including any license, covenant or commitment of any
nature), or subject to any judgment, decree or order of any court or
administrative agency, that would conflict or interfere with (i) the performance
of such Founder's or employee's duties as an officer, employee or director of
the Company; (ii) the use of such Founder's or employee's best efforts to
promote the interests of the Company; or (iii) the Company's business as
conducted or proposed to be conducted. To the best of the Company's knowledge,
no person or entity (including, without limitation, any prior employer of any
Founder or of any other employee of the Company) has any right to or interest in
any inventions, improvements, discoveries or other information assigned to the
Company by such Founder or employee pursuant to the Nondisclosure and
Developments Agreement (in the form attached hereto as Exhibit C) executed by
such Founder or employee, or otherwise.
3.14 Insurance. The Company maintains valid policies for workers'
compensation insurance and insurance related to its properties and business of
the kinds and in the amounts set forth on the Certificate of Insurance attached
hereto as Schedule 3.14.
3.15 Material Contracts and Obligations. Schedule 3.15 sets forth a
list of all material agreements of any nature to which the Company is a party or
by which it is bound, including without limitation (a) each agreement which
requires future expenditures by the Company in excess of $25,000; (b) all
employment and consulting agreements, employee benefit, bonus, pension,
profit-sharing, stock option, stock purchase and similar plans and arrangements,
and distributor and sales representative agreements; (c) any agreement to which
any stockholder, officer or director of the Company, or any "affiliate" or
"associate" of such persons (as such terms are defined in the rules and
regulations promulgated under the Securities Act) is a party, including, without
limitation, any agreement or other arrangement providing for the furnishing of
services by, rental of real or personal property from, or otherwise requiring
payments to, any such person or entity; and (d) any agreement relating to the
Intellectual Property Rights. The Company has delivered to special counsel to
Anthem copies of such of the foregoing agreements as such counsel has requested.
All of such agreements and contracts are valid, binding and in full force and
effect.
3.16 Compliance. The Company has, in all material respects, complied
with all laws, regulations and orders applicable to its present and proposed
business and has all material permits and licenses required thereby. There is no
term or provision of any material mortgage, indenture, contract, agreement or
instrument to which the Company is a party or by which it is bound, or, to the
best knowledge of the Company, of any provision of any state or Federal
judgment, decree, order, statute, rule or regulation applicable to or binding
upon the
- 6 -
7
Company, that materially adversely affects or, so far as the Company may now
foresee, in the future is reasonably likely to materially adversely affect, the
business, prospects, condition, affairs or operations of the Company or any of
its properties or assets. To the best of the knowledge of the Company, none of
the Founders nor any other employee of the Company is in violation of any
contract or covenant (either with the Company or with another entity) relating
to employment, patent, other proprietary information disclosure,
non-competition, or non-solicitation.
3.17 Absence of Changes. Since the Balance Sheet Date, there has been
no material adverse change in the condition, financial or otherwise, net worth
or results of operations of the Company, other than changes occurring in the
ordinary course of business which changes have not, individually or in the
aggregate, had a materially adverse effect on the business, prospects,
properties or condition, financial or otherwise, of the Company.
3.18 Employees. All employees of the Company whose employment
responsibility requires access to confidential or proprietary information of the
Company have executed and delivered Nondisclosure and Developments Agreements in
the form of Exhibit C, and all of such agreements are in full force and effect.
None of the employees of the Company is represented by any labor union, and
there is no labor strike or other labor trouble pending with respect to the
Company (including, without limitation, any organizational drive) or, to the
best knowledge of the Company, threatened.
3.19 ERISA. The Company does not have or otherwise contribute to or
participate in any employee benefit plan subject to the Employee Retirement
Income Security Act of 1974 other than a medical benefit plan with respect to
which the Company has made all required contributions and has complied with all
applicable laws.
3.20 Books and Records. The minute books of the Company contain
complete and accurate records of all meetings and other corporate actions of its
stockholders and its Board of Directors and committees thereof. The stock ledger
of the Company is complete and reflects all issuances, transfers, repurchases
and cancellations of shares of capital stock of the Company.
3.21 Disclosures. Neither this Agreement nor any exhibit hereto, nor
any report, certificate or instrument furnished to any of the Purchasers or
their special counsel in connection with the transactions contemplated by this
Agreement, when read together, contains or will contain any material
misstatement of fact or omits or will omit to state a material fact necessary to
make the statements contained herein or therein not misleading. The Company
knows of no information or fact which has or would have a material adverse
effect on the business, prospects or condition (financial or otherwise) of the
Company that has not been disclosed to the Purchasers in writing.
3.22 Small Business Concern. The Company is a "small business concern"
as defined in section 121.301(c) of Title 13 of the Code of Federal Regulations.
- 7 -
8
3.23 U.S. Real Property Holding Corporation. The Company is not now and
has never been a "United States Real Property Holding Corporation" as defined in
Section 897(c)(2) of the Code and Section 1.897-2(b) of the Regulations
promulgated by the Internal Revenue Service.
4. Representations of the Purchasers. Each of the Purchasers severally
represents and warrants to the Company as follows:
4.1 Investment. Such Purchaser is acquiring the Series B Preferred and
the Series B Conversion Shares, for his or its own account for investment and
not with a view to, or for sale in connection with, any distribution thereof,
nor with any present intention of distributing or selling the same; and, except
as contemplated by this Agreement and the Exhibits hereto, such Purchaser has no
present or contemplated agreement, undertaking, arrangement, obligation,
indebtedness or commitment providing for the disposition thereof.
4.2 Authority. Such Purchaser has full power and authority to enter
into and to perform this Agreement in accordance with its terms. Any Purchaser
that is a corporation, partnership or trust represents that it has not been
organized, reorganized or recapitalized specifically for the purpose of
investing in the Company.
4.3 Experience. Each of the Purchasers has carefully reviewed the
representations concerning the Company contained in this Agreement, has read the
Plan and has made detailed inquiry concerning the Company, its business and its
personnel; the officers of the Company have made available to such Purchaser any
and all written information which it or he has requested and have answered to
such Purchaser's satisfaction all inquiries made by such Purchaser; and such
Purchaser has adequate net worth and means of providing for its or his current
needs and contingencies to sustain a complete loss of its or his investment in
the Company; such Purchaser's overall commitment to investments which are not
readily marketable is not disproportionate to its or his net worth and such
Purchaser's investment in the Series B Preferred will not cause such overall
commitment to become excessive.
4.4 Accredited Investor. Each Purchaser is an Accredited Investor
within the definition set forth in Rule 501(a) of the Securities Act, which
definition is set forth below:
"Accredited investor" shall mean any person who comes within any of
the following categories, or who the issuer reasonably believes
comes within any of the following categories, at the time of the
sale of the securities to that person:
(1) Any bank as defined in section 3(a)(2) of the Act, or any
savings and loan association or other institution as defined in
section 3(a)(5)(A) of the Act whether acting in its individual or
fiduciary capacity; any broker or dealer registered pursuant to
- 8 -
9
section 15 of the Securities Exchange Act of 1934; any insurance
company as defined in section 2(13) of the Act; any investment
company registered under the Investment Company Act of 1940 or a
business development company as defined in section 2(a)(48) of that
Act; any Small Business Investment company licensed by the U.S.
Small Business Administration under section 301(c) or (d) of the
Small Business Investment Act of 1958; any plan established and
maintained by a state, its political subdivisions, or any agency or
instrumentality of a state or its political subdivisions for the
benefits of its employees, if such plan has total assets in excess
of $5,000,000; any employee benefit plan within the meaning of the
Employee Retirement Income Security Act of 1974 if the investment
decision is made by a plan fiduciary, as defined in section 3(21) of
such Act, which is either a bank, savings and loan association,
insurance company, or registered investment adviser, or if the
employee benefit plan has total assets in excess of $5,000,000 or,
if a self-directed plan, with investment decisions made solely by
persons that are accredited investors;
(2) Any private business development company as defined in section
202(a)(22) of the Investment Advisers Act of 1940;
(3) Any organization described in Section 501(c)(3) of the Internal
Revenue Code, corporation, Massachusetts or similar business trust,
or partnership, not formed for the specific purpose of acquiring the
securities offered, with total assets in excess of $5,000,000;
(4) Any director, executive officer, or general partner of the
issuer of the securities being offered or sold, or any director,
executive officer, or general partner of a general partner of that
issuer;
(5) Any natural person whose individual net worth, or joint net
worth with that person's spouse, at the time of his purchase exceeds
$1,000,000;
(6) Any natural person who had an individual income in excess of
$200,000 in each of the two most recent years or joint income with
that person's spouse in excess of $300,000 in each of those years
and has a reasonable expectation of reaching the same income level
in the current year;
- 9 -
10
(7) Any trust, with total assets in excess of $5,000,000, not
formed for the specific purpose of acquiring the securities offered,
whose purchase is directed by a sophisticated person as described in
Section 230.506(b)(2)(ii); and
(8) Any entity in which all of the equity investors are accredited
investors.
(Rule 501(a) of the Securities Act)
4.5 Institutional Investor. NEPA individually represents that it is an
Institutional Investor within the definition set forth in Section 203(c) of the
Pennsylvania Securities Act of 1972, as amended.
5. Conditions to the Obligations of the Purchasers. The obligation of each
of the Purchasers to purchase Series B Preferred at the Initial Closing or any
Subsequent Closing and is subject to the fulfillment, or the waiver by such
Purchaser, of the following conditions on or before the Initial Closing Date or
any Subsequent Closing Date:
5.1 Accuracy of Representations and Warranties. Each representation and
warranty contained in Section 3 shall be true on and as of the Initial Closing
Date or any Subsequent Closing Date, as applicable, with the same effect as
though such representation and warranty had been made on and as of that date.
5.2 Performance. The Company and each of the Founders shall have
performed and complied with all agreements and conditions contained in this
Agreement required to be performed or complied with by the Company or such
Founder prior to or at the Initial Closing or any Subsequent Closing, as
applicable.
5.3 Opinion of Counsel. Each Purchaser shall have received an opinion
from Xxxxxxxx & Xxxxx, counsel for the Company, dated the Initial Closing Date
or any Subsequent Closing Date, addressed to the Purchasers, in the form of
Exhibit D.
5.4 Other Agreements.
(a) Stockholders' Voting Agreement. The Amended and Restated
Stockholders' Voting Agreement attached hereto as Exhibit E (the "STOCKHOLDERS'
VOTING AGREEMENT") shall have been executed and delivered by the Company, by
each of the Purchasers and by each of the Stockholders (as defined therein). All
such action shall have been taken as may be necessary to elect a Board of
Directors of the Company, effective upon the Initial Closing, in accordance with
the Stockholders' Voting Agreement.
- 10 -
11
(b) Registration Rights. The Registration Rights Agreement attached
hereto as Exhibit F (the "REGISTRATION RIGHTS AGREEMENT") shall have been
executed and delivered by the Company, by each of the Purchasers and by each of
the parties identified therein.
(c) Stock Restriction Agreements. Except for those designated
"Exempt Employees" by management prior to Initial Closing or any Subsequent
Closing, all major holders of Common Stock who are employees of the Company
shall have executed and delivered to the Company a Stock Restriction Agreement
substantially in the form attached hereto as Exhibit G.
5.5 Blue Sky Approvals. The Company shall have made, or have made
arrangements satisfactory to both Anthem and NEPA to take, all actions necessary
for the exemptions from the state securities laws of the State of Maryland, the
Commonwealth of Pennsylvania and all other jurisdictions in which the shares of
Series B Preferred are being sold on or before the Initial Closing Date or any
Subsequent Closing Date, or at such time thereafter as may be required by the
applicable statute.
5.6 Certificates and Documents. The Company shall have delivered to
special counsel to Anthem or counsel to the Future Investors, as applicable:
(a) The Articles of Incorporation of the Company, as amended and
restated and in effect prior to the Initial Closing or any Subsequent Closing,
as applicable, certified by the Maryland State Department of Assessments &
Taxation;
(b) Certificates, as of the most recent practicable dates, as to
the corporate good standing of the Company issued by the Maryland State
Department of Assessments & Taxation confirming such good standing on or
immediately prior to the Initial Closing or any Subsequent Closing;
(c) By-laws of the Company, certified by its Secretary or Assistant
Secretary as being in effect of the Initial Closing Date or any Subsequent
Closing Date, as applicable; and
(d) Resolutions of the Board of Directors of the Company,
authorizing and approving all matters in connection with this Agreement and the
transactions contemplated hereby, certified by the Secretary or Assistant
Secretary of the Company as of the Initial Closing Date or any Subsequent
Closing Date.
5.7 [Intentionally Deleted]
5.8 Small Business Concern Documents. The Company shall have
completed, executed and delivered to Anthem a Size Status Declaration on SBA
Form 480 and a Non-Discrimination Certificate on SBA Form 652-D.
- 11 -
12
5.9 Compliance Certificate. The Company shall have delivered to the
Purchasers a certificate, executed by the President of the Company, dated the
Initial Closing Date or any Subsequent Closing Date, as applicable, certifying
to the fulfillment of the conditions specified in subsections 5.1, 5.2, and 5.5
of this Agreement.
5.10 Amendments to By-laws. The Company shall have delivered to the
Purchasers evidence that the By-laws of the Company have been amended to provide
that the Board of Directors hold a regular meeting at least once each quarter
and that any two directors may call a special meeting of the Board of Directors.
5.11 Other Matters. All corporate and other proceedings in connection
with the transactions contemplated by this Agreement and all documents and
instruments incident to such transactions shall be reasonably satisfactory in
substance and form to each of the Purchasers and to Anthem's special counsel,
and the Purchasers and Anthem's special counsel shall have received all such
counterpart originals or certified or other copies of such documents as they may
reasonably request.
6. Conditions to the Obligations of the Company. The obligations of the
Company under subsection 1.2 of this Agreement are subject to fulfillment, on or
before the Closing Date, of each of the following conditions:
6.1 Accuracy of Representations and Warranties. The representations and
warranties of the Purchasers contained in Section 4 shall be true on and as of
the Initial Closing Date or any Subsequent Closing Date with the same effect as
though such representations and warranties had been made on and as of that date.
6.2 Blue Sky Approvals. The Company shall have made, or have made
arrangements satisfactory to both Anthem and NEPA to take, all actions necessary
for the exemptions from the state securities laws of the State of Maryland, the
Commonwealth of Pennsylvania and all other jurisdictions in which the shares of
Series B Preferred are being sold on or before the Initial Closing Date or any
Subsequent Closing Date, or at such time thereafter as may be required by the
applicable statute.
6.3 Purchase Price. Each Purchaser shall have delivered the aggregate
purchase price set forth opposite its name on Exhibit B.
7. Covenants of the Company.
7.1 Inspection. So long as any share of Series B Preferred is
outstanding, the Company shall permit the Purchasers who purchase no less than
10% of the number of shares of Series B Preferred sold hereunder, or any
authorized representative thereof, to visit and inspect the properties of the
Company, including its corporate and financial records, and to discuss its
business and finances with officers of the Company, during normal business hours
following reasonable notice and as often as may be reasonably requested.
- 12 -
13
7.2 Observer Rights. The Company will permit each Purchaser who
purchases no less than 1,929,584 shares of Series B Preferred (including shares
of Common Stock into which such Series B Preferred have been converted and as
adjusted for stock splits, stock dividends, and other recapitalizations), or any
authorized representative thereof, to attend all meetings of the Board of
Directors of the Company, and shall, upon the written request of such holder,
provide him or it with such notice of and other information with respect to such
meetings as are delivered to the directors of the Company. Upon written request
of any such holder, the Company shall notify such holder, within ten days
thereafter, of the taking of any written action by the Board of Directors of the
Company in lieu of a meeting thereof. Any holder exercising his or its rights
under this subsection, and his or its representatives, shall maintain the
confidentiality of all financial, confidential, and proprietary information of
the Company acquired by them in exercising such rights.
7.3 Reserved Employee Shares. The Company will reserve an additional
1,000,000 shares of Common Stock (the "RESERVED EMPLOYEE SHARES"), for issuance
to employees of the Company or promised to employees, vendors, consultants or
any other individual corporation or institution (i.e., the 4,113,535 shares of
Common Stock reserved for such issuances immediately prior to the closing shall
be increased to 5,113,535). The Reserved Employee Shares will be issued from
time to time under such arrangement, contracts or plans as are recommended by
management and approved by the Board of Directors, provided that without the
consent of a majority of the Company's directors, the vesting of any such shares
(or options there for) issued shall not be at a rate in excess of 25.0% of the
aggregate amount granted, per annum, from the date of issuance. Holders of
Reserved Employee Shares shall be required to execute Exempt Employee Stock
Restriction Agreements and Market Stand-Off Agreements, each substantially in
the form of Exhibit H and Exhibit I, respectively, attached hereto. Unless
subsequently agreed to the contrary by the Purchasers, any issuance of shares in
excess of the Reserved Employee Shares will be a dilutive event requiring
adjustments to the conversion prices and will be subject to the Purchasers'
Right of First Refusal as provided under subsection 7.8.
7.4 Financial Statements and Other Information.
(a) So long as any of the Series B Preferred is outstanding, the
Company will deliver to the Purchasers:
(i) within 90 days after the end of each fiscal year of the
Company, commencing with the fiscal year ending December 31, 1998, an audited
balance sheet of the Company as at the end of such year and audited statements
of income and of cash flow of the Company for such year, certified by certified
public accountants retained pursuant to Section 8.9 of this Agreement, and
prepared in accordance with generally accepted accounting principles; and
(ii) within 15 business days after the end of each fiscal
quarter of the Company, an unaudited balance sheet of the Company as at the end
of such
- 13 -
14
quarter, and unaudited statements of income and of cash flow of the Company for
such fiscal quarter;
(iii) within 15 business days after the end of each month, an
unaudited balance sheet of the Company as at the end of such month and unaudited
statements of income and of cash flow of the Company including annual budgets of
the Company for such month and for the current fiscal year to the end of such
fiscal month, setting forth in comparative form the Company's projected
financial statements for the corresponding periods for the current fiscal year;
(iv) within 10 business days after the discovery by the Company
or notification to the Company that the Company is not in compliance with the
material terms of this Agreement or of any other material agreement to which the
Company is a party, a detailed statement outlining such noncompliance or
default;
(v) within 10 business days of delivery, such other notices,
information and data with respect to the Company as the Company delivers to the
holders of its Common Stock, the Securities and Exchange Commission or any
securities exchange on which the capital stock of the Company may be listed;
(vi) as soon as is reasonably practicable, such other
information and data as the Purchasers may from time to time reasonably request;
and
(vii) as soon as available, but no less than 30 days prior to
the commencement of each new fiscal year, an annual operating plan to be
presented to and approved by a majority of the Board of Directors prior to the
beginning of each fiscal year; provided however, that the Company shall have the
ability, at any time, to submit a new or revised annual operating plan for
approval by a majority of the Board of Directors of the Company at a meeting
duly called for such purpose.
(b) The foregoing financial statements shall be prepared on a
consolidated basis if the Company then has any subsidiaries. The financial
statements delivered pursuant to clauses (ii) and (iii) of paragraph (a) shall
be accompanied by a certificate of the chief executive officer and the chief
financial officer, if any, of the Company stating that such statements have been
prepared in accordance with generally accepted accounting principles
consistently applied (except as noted) and fairly present the financial
condition of the Company at the date thereof and for the periods covered thereby
(subject to year-end audit adjustments). The financial statements delivered
pursuant to clause (iii) of paragraph (a) shall also be accompanied by a
certificate from the chief financial officer, if any, and the chief executive
officer of the Company stating, to the best of their knowledge, after due
inquiry of such officer, whether the Company is in material compliance with this
Agreement, its Articles of Incorporation or By-laws or any material indenture,
lease, agreement or other instrument to which the Company is a party or by which
it or any of its properties is bound.
- 14 -
15
7.5 Material Changes and Litigation. The Company will promptly notify
the Purchasers of any material adverse change in the business, properties,
assets or condition, financial or otherwise, of the Company and of any
litigation or governmental proceeding or investigation pending or, to the best
knowledge of the Company, threatened against the Company, or against any
Founder, officer, director, key employee or principal stockholder of the Company
materially affecting or which, if adversely determined, would materially
adversely affect the Company's present or then proposed business, properties,
assets or condition (financial or otherwise).
7.6 Key Man Insurance. The Company will maintain term life insurance
upon the lives of its key employees in such coverage amounts as the Board of
Directors shall determine is reasonable.
7.7 Nondisclosure and Non-Competition Agreements. The Company will
require all persons now or hereafter employed by the Company who have access to
confidential and proprietary information of the Company to enter into
Nondisclosure and Developments Agreements substantially in the form of Exhibit C
or such other form as may be approved by the Board of Directors of the Company;
and will require certain persons, designated by the Board of Directors, now or
hereafter employed by the Company, to enter into employment agreements
substantially in the form of Exhibit J or such other form as may be approved by
the Board of Directors of the Company.
7.8 Right of First Refusal.
(a) The Company hereby grants to the Purchasers a right of first
refusal, participating concurrently with and proportionately with the holders of
the shares of Series A Preferred, to purchase, on a pro rata basis, all or any
part of New Securities (as defined below) that the Company may, from time to
time, propose to sell and issue, subject to the terms and conditions set forth
below. A Purchaser's pro rata share, for purposes of this subsection 7.8, shall
equal a fraction, the numerator of which is the number of shares of Common Stock
then held by such Purchaser or issuable upon conversion or exercise of any
Series B Preferred, convertible securities, options, rights or warrants then
held by such Purchaser, and the denominator of which is the total number of
shares of Common Stock then outstanding plus the number of shares of Common
Stock issuable upon conversion or exercise of then outstanding Series A
Preferred and Series B Preferred, and any outstanding convertible securities,
options, rights or warrants.
(b) "NEW SECURITIES" shall mean any capital stock of the Company
whether now authorized or not, and rights, options or warrants to purchase
capital stock, and securities of any type whatsoever that are, or may become,
convertible into capital stock; provided, however, that the term "New
Securities" does not include (i) the Series B Preferred issuable under this
Agreement or the Series A or Series B Conversion Shares; (ii) securities offered
to the public pursuant to a registration statement; (iii) securities issued for
the acquisition of another corporation by the Company by merger, purchase of
substantially all the assets of such
- 15 -
16
corporation or other reorganization resulting in the ownership by the Company of
not less than 51% of the voting power of such corporation; (iv) not more than
5,113,535 shares of Common Stock issued to employees or consultants of the
Company pursuant to a stock option plan, employee stock purchase plan,
restricted stock plan or other employee stock plan or agreement; or (v)
securities issued as a result of any stock split, stock dividend or
reclassification of Common Stock, distributable on a pro rata basis to all
holders of Common Stock.
(c) In the event the Company intends to issue New Securities, it
shall give each original purchaser of Series A Preferred and each Purchaser
(collectively, the "PREFERRED PURCHASERS") written notice of such intention,
describing the type of New Securities to be issued, the price thereof and the
general terms upon which the Company proposes to effect such issuance. Each
Preferred Purchaser shall have 20 days from the date of any such notice to agree
to purchase all or part of its or his pro rata share of such New Securities for
the price and upon the general terms and conditions specified in the Company's
notice by giving written notice to the Company stating the quantity of New
Securities to be so purchased. Each Preferred Purchaser shall have a right of
over allotment such that if any Preferred Purchaser fails to exercise his or its
right hereunder to purchase his or its total pro rata portion of New Securities,
the other Preferred Purchasers may purchase such portion on a pro rata basis, by
giving written notice to the Company within five days from the date that the
Company provides written notice to the other Preferred Purchasers of the amount
of New Securities with respect to which such non-purchasing Preferred Purchaser
has failed to exercise its or his right hereunder. A Preferred Purchaser's pro
rata share, for purposes of this subsection 7.8(c) only, shall equal a fraction,
the numerator of which is the number of shares of Series A Preferred added to
the number of shares of Series B Preferred then held by such Preferred
Purchaser, and the denominator of which is the total number of shares of Series
A Preferred and shares of Series B Preferred issued and outstanding.
(d) In the event any Preferred Purchaser fails to exercise the
foregoing right of first refusal with respect to any New Securities within such
20-day period (or the additional five-day period provided for over allotments),
the Company may within 90 days thereafter sell any or all of such New Securities
not agreed to be purchased by the Preferred Purchasers, at a price and upon
general terms no more favorable to the purchasers thereof than specified in the
notice given to each Preferred Purchaser pursuant to paragraph (c) above. In the
event the Company has not sold such New Securities within such 90-day period,
the Company shall not thereafter issue or sell any New Securities without first
offering such New Securities to the Preferred Purchasers in the manner provided
above.
(e) A Preferred Purchaser's right of first refusal under this
subsection 7.8 will be limited to the extent that counsel to the Company advises
the Board of Directors that (i) the exercise of the right by a Preferred
Purchaser would not qualify under the exemption from registration under the
state and federal securities laws contemplated to be relied upon by the Company,
(ii) the exercise of the right by a Preferred Purchaser cannot be accommodated
under any other exemption, or (iii) compliance with the available exemption
would be unduly burdensome or costly to the Company.
- 16 -
17
(f) Each of Anthem, NEPA, Homa, Faint, and Xxxxxxxxxx agrees that
the terms and conditions set forth in this Section 7.8 shall amend and supersede
in their entirety, the terms and conditions set forth in Section 8.8 of that
certain Series A Preferred Stock Purchase Agreement dated November 22, 1996 (the
"SERIES A PREFERRED STOCK PURCHASE AGREEMENT") and that they hereby waive their
rights under such Section 8.8 and that the terms of such Section 8.8 thereof
shall be of no further force and effect.
7.9 Auditor. The Company shall retain a firm of certified public
accountants of established national reputation known as one of the "Big 6" to
audit its books and records at least annually.
7.10 Additional Covenants. So long as any of the Series B Preferred
are outstanding, the Company agrees as follows:
(a) The Company will promptly pay and discharge, or cause to be
paid and discharged, when due and payable, all lawful taxes, assessments, and
governmental charges or levies imposed upon the income, profits, property, or
business of the Company or any subsidiary; provided, however, that any such tax,
assessment, charge, or levy need not be paid if the validity thereof shall
timely be contested in good faith by appropriate proceedings and if the Company
shall have set aside on its books adequate reserves therefor; and provided,
further, that the Company will pay all such taxes, assessments, charges, or
levies forthwith upon the commencement of proceedings to foreclose any lien that
may have attached to the income, profits, property, or business of the Company
or any subsidiary as security therefor. The Company will promptly pay or cause
to be paid when due, or in conformance with customary trade terms, all other
indebtedness incident to the operations of the Company;
(b) The Company will keep its properties and those of its
subsidiaries in good repair, working order, and condition, reasonable wear and
tear excepted, and from time to time make all needful repairs, renewals,
replacements, additions, and improvements thereto; and the Company will at all
times comply with the provisions of all material leases to which the Company or
any of its subsidiaries is a party or under which any of them occupies property
so as to prevent any loss or forfeiture thereof or thereunder;
(c) The Company will keep its assets that are of an insurable
character insured by financially sound and reputable insurers against loss or
damage by fire, extended coverage, and explosion insurance in amounts customary
for companies in similar businesses similarly situated; and the Company will
maintain, with financially sound and reputable insurers, insurance against other
hazards, risks, and liabilities to persons and property to the extent and in the
manner customary for companies in similar businesses similarly situated;
(d) The Company will keep true records and books of account in
which full, true and correct entries will be made of all material dealings or
transactions in relation
- 17 -
18
to its business and affairs in accordance with generally accepted accounting
principles applied on a consistent basis;
(e) The Company will comply with the requirements of all applicable
laws, rules, regulations, and orders of any governmental authority, a breach of
which could have a material adverse effect on its business or credit;
(f) The Company shall maintain in full force and effect its
corporate existence, rights, and franchises and all licenses and other rights to
use patents, processes, licenses, trademarks, trade names, or copyrights owned
or possessed by it or any subsidiary and deemed by the Company to be necessary
to the conduct of its business; and
(g) Within the statutorily required time frame, the Company will
take all actions necessary to effect the exemptions from state securities laws
of the State of Maryland, the Commonwealth of Pennsylvania and all such other
jurisdictions in which the shares of Series B Preferred are sold.
7.11 Expenses of Directors. The Company shall promptly reimburse in
full each director of the Company who is not an employee of the Company and who
was elected as a director solely or in part by the holders of Series B Preferred
for all of his reasonable out-of-pocket expenses incurred in attending each
meeting of the Board of Directors of the Company or any committee thereof.
7.12 Reservation of Common Stock. The Company shall reserve and
maintain a sufficient number of shares of Common Stock for issuance upon
conversion of all of the outstanding Series B Preferred.
7.13 Termination of Covenants. The covenants of the Company contained
in this Section 7 shall terminate, and be of no further force or effect, upon
the earlier of (i) the date when less than 10% of the number of shares of Series
B Preferred issued pursuant to this Agreement (as adjusted for stock splits,
stock dividends, and other recapitalizations) are outstanding, and (ii) the
effective date of a registration statement filed by the Company with the
Commission for a public offering and sale of securities of the Company (other
than a registration statement on Form S-8 or Form S-4, or their successors, or
any other form for a limited purpose, or any registration statement covering
only securities proposed to be issued in exchange for securities or assets of
another corporation) (a "REGISTRATION STATEMENT") covering the Company's first
public offering of Common Stock, resulting in gross proceeds exceeding
$15,000,000, at a price per share not less than $3.50 (as adjusted for stock
splits, stock dividends, recapitalizations and similar events) (a "QUALIFIED
PUBLIC OFFERING").
7.14 Termination of Section 8.11 of the Series A Preferred Stock
Purchase Agreement. Each of Anthem, NEPA, Homa, Faint, and Xxxxxxxxxx agree that
the terms and conditions set forth in Section 8.11 the Series A Preferred Stock
Purchase Agreement shall
- 18 -
19
terminated with respect to such Section, as such terms and conditions are
contained in the Charter, and that the terms of such Section 8.11 thereof shall
be of no further force and effect.
7.15 Termination of Section 8.14 of the Series A Preferred Stock
Purchase Agreement. Each of Anthem, NEPA, Homa, Faint, and Xxxxxxxxxx agree that
the terms and conditions set forth in Section 8.14 the Series A Preferred Stock
Purchase Agreement shall terminated with respect to such Section, as such terms
and conditions are contained in the Charter, and that the terms of such Section
8.14 thereof shall be of no further force and effect.
8. Successors and Assigns. Except as provided in Section 9, the provisions
of this Agreement shall be binding upon, and inure to the benefit of, the
respective successors, assigns, heirs, executors and administrators of the
parties hereto.
9. Transfers of Certain Rights. The rights granted to a Purchaser under
Section 7.8 may be transferred by such Purchaser to another Purchaser, to any
affiliate or to any person or entity acquiring at least 5% of the number of
shares of Series B Preferred Stock originally issued by the Company or 5% of the
number of shares of Series A Preferred Stock originally issued by the Company;
provided, however, that the Company is given written notice by the transferee at
the time of such transfer stating the name and address of the transferee and
identifying the securities with respect to which such rights are being assigned.
10. Confidentiality. Each Purchaser agrees that he or it will keep
confidential and will not disclose or divulge any confidential, proprietary or
secret information which such Purchaser may obtain from the Company pursuant to
financial statements, reports and other materials submitted by the Company to
such Purchaser pursuant to this Agreement, or pursuant to visitation or
inspection rights granted hereunder, unless such information is known, or until
such information becomes known, to the public other than as a result of a
disclosure by such Purchaser; provider, however, that a Purchaser may disclose
such information (i) to his or its attorneys, accountants, consultants, and
other professionals to the extent necessary to obtain their services in
connection with its investment in the Company, (ii) to any prospective purchaser
of any Series B Preferred from such Purchaser as long as such prospective
purchaser agrees in writing to be bound by the provisions of this Section, or
(iii) to any affiliate of such Purchaser or to a partner, shareholder or
subsidiary of such Purchaser.
11. Survival of Representations and Warranties. All agreements,
representations and warranties contained herein shall survive the execution and
delivery of this Agreement and the closing of the transactions contemplated
hereby until the consummation of a Qualified Public Offering.
12. Expenses. The Company shall pay the reasonable attorneys fees up to a
maximum of $25,000 and the out-of-pocket expenses of Piper & Marbury L.L.P.,
special counsel to Anthem and NEPA, in connection with the preparation of this
Agreement and the closing of the transactions contemplated hereby. The Company
shall pay the reasonable attorneys fees up to a
- 19 -
20
maximum of $5,000 of counsel to the New Investors in connection with their
review of this Agreement and the related documents.
13. Notices. All notices, requests, consents, and other communications
under this Agreement shall be in writing and shall be delivered by hand or
mailed by first class certified or registered mail, return receipt requested,
postage prepaid:
If to the Company, at Sequoia Software Corporation, Overlook Center,
0000 Xxxx Xxxxxx Xxxx, Xxxxxxxx, Xxxxxxxx 00000, Attention: President, or at
such other address or addresses as may have been furnished in writing by the
Company to the Purchasers, with a copy to Xxx X. Xxxxxxxx, Esq., Xxxxxxxx &
Xxxxx, Ninth Floor, The World Trade Center, 000 Xxxx Xxxxx Xxxxxx, Xxxxxxxxx
Xxxxxxxx 00000-0000;
If to NEPA or Anthem, at its address set forth in Exhibit B, or at such
other address or addresses as may have been furnished to the Company in writing
by the Purchaser, with a copy to Xxxxx X. Xxxxxxxx, Esq., Piper & Marbury
L.L.P., 0000 Xxxxxxxxxx Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000; or
If to the New Investors, at his or her address set forth in Exhibit B,
or at such other address or addresses as may have been furnished to the Company
in writing by the Purchaser, with a copy to Xxxxx XxXxxxxxx, Esquire, Xxxxxxx &
Xxxxxx, LLP 000 Xxxx Xxxxxx, Xxxxx 0000, Xxxxxx, Xxxxx 00000-0000; or
If to a Founder, at his address set forth below his signature to this
Agreement.
Notices provided in accordance with this Section 13 shall be deemed
delivered upon personal delivery or two business days after deposit in the mail.
14. Brokers. Except as disclosed in Schedule 14, the Company is not
subject to an existing agreement with any finder and no fees will be paid by the
Company to any such finder in regard to the transaction contemplated by this
Agreement. The Purchasers are not responsible for the payment of any finder's
fees in connection with the transaction contemplated herein. The Company and
each of the Purchasers will indemnify and save the other parties harmless from
and against any and all claims, liabilities or obligations with respect to
brokerage or finders' fees or commissions, or consulting fees in connection with
the transactions contemplated by this Agreement asserted by any person on the
basis of any statement or representation alleged to have been made by such
indemnifying party. Any shares granted to a finder in lieu of cash shall not
increase the pre-investment valuation above $15,000,000.
15. Entire Agreement. This Agreement embodies the entire agreement and
understanding between the parties hereto with respect to the subject matter
hereof and supersedes all prior agreements and understandings relating to such
subject matter.
- 20 -
21
16. Amendments and Waivers. Except as otherwise expressly set forth in
this Agreement, any term of this Agreement may be amended and the observance of
any term of this Agreement may be waived (either generally or in a particular
instance and either retroactively or prospectively), with the written consent of
the Company and the holders in interest of no less than 66 2/3% in interest of
the shares of Series B Preferred and the Series B Conversion Shares taken
together; provided, that subsection 7.8 may be amended or waived only with the
consent of the holders in interest of no less than 66 2/3% of the shares of
Series B Preferred and the shares of Series A Preferred taken together as a
single class, and no condition set forth in Section 6 may be waived with respect
to any Purchaser who does not consent thereto. Any amendment or waiver effected
in accordance with this Section 16 shall be binding upon each holder of any
shares of Series B Preferred (including holders of Series B Conversion Shares),
each future holder of all such securities and the Company. No waivers of or
exceptions to any term, condition or provision of this Agreement, in any one or
more instances, shall be deemed to be, or construed as, a further or continuing
waiver of any such term, condition or provision.
17. Community Benefit Activities. So long as any share of Series B
Preferred is owned by Xxxxxx, xxx Company will use its best efforts to support
community activities designed to support low and moderate income neighborhoods
in the areas surrounding its headquarters or other officers. Such activities
shall include, but not be limited to, using its best efforts to hire residents
of low and moderate income neighborhoods and use vendors of goods and services
from such neighborhoods; provided, however, that this provision shall in no way
obligate the Company to compromise its employment or vendor standards or take
any other action not in the Company's best interests. At the request of Xxxxxx,
xxx Company agrees to provide a list of employees by census tract at the Initial
Closing or any Subsequent Closing and at the end of each calendar year
thereafter.
18. Counterparts. This Agreement may be executed in several counterparts,
each of which shall be deemed an original, but all of which, when taken
together, shall constitute one and the same instrument.
19. Headings. The headings of the sections, subsections, and paragraphs of
this Agreement have been added for convenience only and shall not be deemed to
be a part of this Agreement.
20. Severability. The invalidity or unenforceability of any provision of
this Agreement shall not affect the validity or enforceability of any other
provision.
21. Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Maryland.
- 21 -
22
IN WITNESS WHEREOF, the undersigned have hereunto set
their hands as of the day and year first above written.
SEQUOIA SOFTWARE CORPORATION:
By: /s/ XXXXXXX X. FAINT
-------------------------------------------
Title: Chairman and CEO
----------------------------------------
ANTHEM CAPITAL, L.P.:
By: Anthem Capital Partners, L.P.
General Partner
By: Anthem Capital Partners, Inc.
General Partner
By: /s/ XXXXXXX X. XXXX XX
-------------------------------------------
Title:
----------------------------------------
NEPA VENTURE FUND II, L.P.
By: NEPA II Management Corporation
Its: General Partner
By: /s/ XXXX XXXXXX
-------------------------------------------
Xxxx Xxxxxx
Vice President
0000 Xxxxx Xxxxxxxxx
Xxxxx 000
Xxxxxx, XX 00000
FOUNDERS:
/s/ XXXX WESKER
----------------------------------------------
Xxxx Wesker
/s/ XXXX XXXXX
----------------------------------------------
Xxxx Xxxxx
- 00 -
00
XXXXXX XXXXXX XXXX XXXXX XXXXXX
APPROVED: - TRUST B
By: /s/ MIRO VRANAC By: /s/ X.X. XXXXXXX, TRUSTEE
--------------------------------- --------------------------------
Title: Miro Vranac, Jr., Member
Advisory Board Title: X.X. Xxxxxxx, Trustee
----------------------------- -----------------------------
XXXX XXXXXX XXXX TRUST -
XXXX XXXXXXXXXX
By: /s/ XXXX X. XXXXXXXXXX, TRUSTEE By: /s/ MIRO VRANAC
-------------------------------
Name: Xxxx X. Xxxxxxxxxx, Trustee --------------------------------
----------------------------- Name: Miro Vranac, Jr., Trustee
------------------------------
/s/ XXXX XXXX XXXXXXXXXX
-----------------------------------
Xxxx Xxxx Xxxxxxxxxx
/s/ XXXXX X'XXXXX
-----------------------------------
Xxxxx X'Xxxxx
FOR PURPOSES OF SECTION 7.8 ONLY
/s/ XXXXXXX X. FAINT, JR.
----------------------------------
Xxxxxxx X. Faint, Jr.
/s/ XXXXXXX X. XXXX
----------------------------------
Xxxxxxx X. Xxxx
/s/ XXXXX X. XXXXXXXXXX
----------------------------------
Xxxxx X. Xxxxxxxxxx
- 23 -
24
Schedule I
NEW INVESTORS INVESTMENT
Xxxxxx Xxxxxx Xxxx Trust Estate - Trust B $1,450,000
Xxxx Xxxx-Xxxxxx Trust - Xxxx Xxxxxxxxxx $500,000
Xxxx Xxxx Xxxxxxxxxx $50,000
Xxxxx X'Xxxxx $500,000
Total for New Investors $2,500,000
25
Exhibit B
NUMBER OF SHARES OF
SERIES B CONVERTIBLE AGGREGATE PURCHASE
INVESTOR NAME AND ADDRESS PREFERRED STOCK PRICE
PURCHASED
===============================================================================================================
Anthem Capital, L.P.
00 Xxxxx Xxxxxxx Xxxxxx
Xxxxx 000
Xxxxxxxxx, Xxxxxxxx 00000-0000 1,010,290 $683,259.60
NEPA Venture Fund II, L.P.
0000 Xxxxx Xxxxxxxxx
Xxxxx 000
Xxxxxx, Xxxxxxxx 00000 505,145 $341,629.29
Xxxxxx Xxxxxx Xxxx Trust Estate - Trust B
Attn: X.X Xxxxxxx, Trustee
0000 Xxxxxx Xxxx, Xxxxx 0000
Xxxxxx, Xxxxx 00000 2,144,019 $1,450,000.00
Xxxx Xxxx-Xxxxxx Trust -
Xxxx Xxxxxxxxxx
Attn: Miro Vranac, Jr., Trustee
0000 Xxxxxx Xxxx, Xxxxx 0000
Xxxxxx, Xxxxx 00000 739,317 $500,000.00
Xxxx Xxxx Xxxxxxxxxx
0000 Xxxxxx Xxxx, Xxxxx 0000
Xxxxxx, Xxxxx 00000 73,931 $50,000.00
Xxxxx X'Xxxxx
000 Xxxxxxx Xxxxxx Xxxxx
Xxxxx 000
Xxxxxxx Xxxxx, XX 00000 739,317 $500,000.00
Totals 5,212,019 $ 3,524,888.89
